3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Gynecologic
37
Thoracic
28
CNS
18
Sarcoma
5
Other hematologic neoplasm
3
Tumor-Agnostic
2
Lymphoid
2
Endocrine
2
Plasma cell
1
Other solid neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Interventions
Ipilimumab
101
pembrolizumab
94
Nivolumab
87
Cyclophosphamide
69
fludarabine phosphate
55
aldesleukin
52
Interleukin-2
39
Dacarbazine
35
Vemurafenib
31
fludarabine
30
trametinib
29
dabrafenib
29
Temozolomide
28
Whole-Body Irradiation
21
Aminolevulinic Acid
21
Carboplatin
20
CTLA-4 Antigen
20
Bevacizumab
20
Radiotherapy
19
Peripheral Blood Stem Cell Transplantation
19
Radiosurgery
18
Tacrolimus
17
Mycophenolic Acid
17
Paclitaxel
16
HhAntag691
16
3-ingenyl angelate
16
Busulfan
15
Introns
14
Antilymphocyte Serum
14
encorafenib
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Topotecan
×
Dermatologic
×
Clear all
No trials found.